Portfolio News

Student Loan Platform Projects $1 Billion Impact for Users

Candidly, a platform that helps employees reduce their student debt and increase their savings, surpassed $1 billion in projected dollar impact in 2023, according to its annual report. The number represents the total amount of dollar impact Candidly users should receive as a result of actions taken on the platform. Users—most of whom have access to Candidly through their employer—can use the AI-powered platform to help tackle their student debt as well as plan and pay for college. The platform...
Read more...

Candidly Releases Inaugural Impact Report

Candidly, the leading AI-driven student debt and savings optimization platform, released today its 2023 Impact Report, which highlights customer profiles and shares key milestones met by the company in 2023. Achievements featured in the report include surpassing $1 billion in projected impact over the life of the loans of its end users, the vast majority of whom are offered Candidly as a workplace benefit from their employer. This number represents the total dollar impact that Candidly users are on track...
Read more...

Elizabeth Banks Just Told Us About Her Morning Routine, Including the Drink That’s Her “Daily Ritual”

In this exclusive Q&A with EatingWell, Banks reveals her hosting expertise as the co-owner of Archer Roose, the canned wine brand that specializes in sustainable sourcing and packaging. EatingWell: What’s your No. 1 hosting tip for any gathering? Banks: I love Offering a signature cocktail like [Archer Roose’s] Bubbly Rosé spritzer with some berries can elevate the experience. Archer Roose adds a touch of elegance to any setting, and their canned convenience is a host's best friend. EatingWell: What are...
Read more...

Windgap Medical: Injecting Simplicity Into Complex Drug Delivery

Injectable formulations are the fastest growing segment in the pharmaceutical industry. According to Precedence Research, the global injectable drug delivery market reached U.S. $561 billion in 2021 and is expected to surpass $1,224 billion by 2030. Given the astounding 40-70% of patients in the US who are noncompliant with their drug regimens, any simplification of administration is a win for patients, caregivers, providers and society at large.5 Recognizing this need, along with the demand for improved patient experience and desire...
Read more...

DeepLook Medical Raises $1.7M for AI-Driven Cancer Detection in Dense Breast Tissue

US-based healthtech company DeepLook Medical has raised $1.7M to enhance cancer detection in dense breast tissue through advanced visual enhancement technology. The company has introduced a pioneering AI technology platform tailored for identifying suspicious masses in women with dense breasts. This innovation is significant as approximately 45% of women have dense breasts, which increases their risk of breast cancer. Traditional mammograms can miss nearly half of cancers in dense breasts, which poses a significant challenge in early cancer detection. Read...
Read more...

Zylö’s ‘Powered by Z-pods®’ technology incorporated into BosleyMD’s new product line

Zylö’s Z-pod® topical delivery platform is being used by BosleyMD—the Thinning Hair Authority™—as a key feature in their newly launched product line, Revive+ Densifying Foam. BosleyMD is currently offering a male version and a female version through CVS and online (see link below); distribution through Walmart and Ulta Beauty is expected soon. Cable TV and online advertising will be used to promote the products. Read more >>
Read more...

Looking at the Life Sciences Industry in South Carolina

In recent years, South Carolina has become a hub of sorts for the life sciences and biotech industries. The Palmetto State has more than 1,000 companies – large and small, established and startup – that are making an impact on the local community and the world at large. Integrated Media Publishing hosted a roundtable discussion with four of the leaders in the biotech world on Jan. 4, 2024. Q. The life sciences industry has been growing. The annual economic impact...
Read more...

Corbus Pharmaceuticals Announces Pricing of Public Offering

Corbus Pharmaceuticals Holdings, Inc., a precision oncology company with a diversified portfolio, today announced the pricing of an underwritten public offering of 4,325,000 shares of its common stock at a public offering price of $19.00 per share, for a total public offering size of approximately $82.2 million, before deducting underwriting discounts and estimated offering expenses. In addition, Corbus has granted the underwriters a 30-day option to purchase up to an additional 648,750 shares of its common stock on the same...
Read more...

401(k) Real Chat: Laurel Taylor

Retirement industry thought leaders answer three probing questions on critical issues, providing an open, honest and candid dialogue. This week, we host Laurel Taylor, founder & CEO at Candidly, which helps DC plan sponsors help their employees better manage their student loans. Read more >>
Read more...